Simplex Trading, LLC E Ffector Therapeutics, Inc. Transaction History

Simplex Trading, LLC

  • $2.98 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024
BUY
$0.37 - $0.69 $641 - $1,197
1,735 New
1,735 $0
Q2 2023

Aug 04, 2023
BUY
$0.35 - $1.39 $3,541 - $14,065
10,119 New
10,119 $8,000
Q4 2022

Feb 02, 2023
BUY
$0.38 - $0.66 $1,106 - $1,921
2,911 Added 51.19%
8,598 $3,000
Q3 2022

Nov 04, 2022
BUY
$0.08 - $1.41 $443 - $7,819
5,546 Added 3933.33%
5,687 $3,000
Q2 2022

Aug 03, 2022
BUY
$1.3 - $3.84 $183 - $541
141 New
141 $0

Others Institutions Holding EFTR

# of Institutions
6
Shares Held
6.53M
Call Options Held
0
Put Options Held
0
View Full List

About eFFECTOR Therapeutics, Inc.

EFTR Quotes by TradingView
  • Ticker EFTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,452,800
  • Description
  • eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-sma...
More about EFTR
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email